CPXCR1 Antikörper (AA 151-250) (Cy3)
Kurzübersicht für CPXCR1 Antikörper (AA 151-250) (Cy3) (ABIN1416329)
Target
Alle CPXCR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-250
-
Homologie
- Human,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CPXCR1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CPXCR1 (CPX Chromosome Region, Candidate 1 (CPXCR1))
-
Andere Bezeichnung
- CPXCR1
-
Hintergrund
-
Synonyms: Cancer/testis antigen 77, CPX chromosome region, candidate 1, CPX candidate region 1 protein, CPX chromosomal region candidate gene 1 protein, CPX chromosomal region candidate gene 1 protein homolog, CPX chromosome region, candidate 1, CT77, Gm1143, CPXCR_HUMAN.
Background: CPXCR1 is widely expressed in fetal tissues, including the tongue, mandible and palate with an unknown function. Cleft palate most commonly occurs as a sporadic multifactorial disorder with a clear but difficult to define genetic component. As a semi-dominant disorder, X-linked cleft palate (CPX) provides a useful model to investigate a congenital defect that is little influenced by non-genetic factors.
-
Gen-ID
- 53336
Target
-